Sein Adjuvant
NATALEE (CLEE011O12301C)
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negartive Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
Paris, Saint-Cloud
JEAN-YVES PIERGA, JEAN-YVES PIERGA